Conference Date & Venue
Omaha Marriott Downtown at the Capitol District
Support Construction of Binaytara's Cancer Hospital in Nepal
Event Description
This CME-accredited oncology conference, Best of Oncology 2026, Omaha, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.
Expert faculty will provide a curated review and clinical interpretation of significant research findings reported at the 2026 American Society of Clinical Oncology Annual Meeting, along with other recent peer-reviewed data relevant to contemporary practice.
Through didactic sessions, panel discussions, and case-based learning, faculty will translate emerging evidence into practical strategies for real-world application. The program emphasizes integration of new therapeutic advances, individualized treatment selection, and proactive toxicity management within a multidisciplinary, patient-centered model of care. This activity is intended for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals involved in oncology care.
Target Audience
- Medical Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Oncology Residents / Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Oncology Pharmacists
Contact Us
Phone: 425-361-0029
Email: sponsorships@binaytara.org
About Binaytara
Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.
As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.
As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.
We invite companies interested in improving equitable access to cancer care to support our efforts.
